Arkema shares fall 6.5% over the week after Kepler's target cut
The specialty chemicals company declines in a Paris market trending lower. It has slipped back below the technical levels it had regained after its results, as two brokers have just adjusted their price targets.
A share price below its three moving averages, 5.6% under the MA200
The Arkema share falls 1.26% to €55.00 intraday, while the CAC 40 loses 1.11%. It is now below its MA20 (€57.01, a gap of 3.53%), its MA50 (€56.21) and its MA200 (€58.27, a gap of 5.61%). This decline erases part of the rebound observed after the third-quarter results were published, when the stock had gained 7.5% in one week. The decline now reaches 6.62% over seven days.
The support at €54.30 is around 1.3% below the current price, and the RSI at 38 remains in a neutral zone.
The quarter's results, with EBITDA of €332 million up 7%, relied mainly on prices rather than volumes. At the publication on November 5, 2026, management had stated it did not expect any improvement in external conditions in the coming months.
Kepler Cheuvreux and Berenberg lower their price targets
Two brokerage firms adjusted their position this week. Kepler Cheuvreux cut its target yesterday from €60 to €47 with a reduce rating, a level nearly 15% below the current price.
Berenberg had lowered its target the day before from €61 to €58, while keeping its hold rating, which leaves a potential of about 5.5%.
The gap between these two targets exceeds €10, a sign of very different views on the chemical company's outlook. The stock has also fallen about 9% over three months, and the next technical level to watch is the €54.30 support.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
« Nous ne prévoyons pas d'amélioration des conditions externes dans les prochains mois »
Outlook / guidance
Management commentary: « Arkema est en ligne avec son objectif de réaliser un EBITDA 2026 légèrement supérieur à l'an dernier à taux de change constants »
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.